These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12096481)

  • 1. [Effect of autologous peripheral blood stem cell transplantation for multiple myeloma: a multi-institutional survey].
    Inaba W; Shimazaki C
    Rinsho Ketsueki; 2002 May; 43(5):337-40. PubMed ID: 12096481
    [No Abstract]   [Full Text] [Related]  

  • 2. Autologous stem-cell transplantation for multiple myeloma.
    Louw VJ; Louw H; Webb MJ
    N Engl J Med; 2009 Sep; 361(11):1118-9; author reply 1119. PubMed ID: 19741236
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta-2-microglobulin level predicts outcome following autologous hematopoietic stem cell transplantation in patients with multiple myeloma.
    Stella-Holowiecka B; Czerw T; Holowiecka-Goral A; Giebel S; Wojnar J; Holowiecki J
    Transplant Proc; 2007 Nov; 39(9):2893-7. PubMed ID: 18022010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients.
    O'Shea D; Giles C; Terpos E; Perz J; Politou M; Sana V; Naresh K; Lampert I; Samson D; Narat S; Kanfer E; Olavarria E; Apperley JF; Rahemtulla A
    Bone Marrow Transplant; 2006 Apr; 37(8):731-7. PubMed ID: 16501593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic esophageal ulcers after autologous hemopoetic stem cell transplant: possible role of IgA levels.
    Dang S; Atiq M; Krishna S; Lamps LW; Olden KW; Aduli F
    Ann Hematol; 2008 Dec; 87(12):1031-2. PubMed ID: 18633617
    [No Abstract]   [Full Text] [Related]  

  • 6. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients.
    Terpos E; Apperley JF; Samson D; Giles C; Crawley C; Kanfer E; Olavarria E; Goldman JM; Rahemtulla A
    Bone Marrow Transplant; 2003 Feb; 31(3):163-70. PubMed ID: 12621476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose chemotherapy and autologous peripheral blood stem cell transplantation in high-risk multiple myeloma.
    Murakami H; Fujii H; Inaba T; Shimazaki C; Okamoto S; Miwa A; Sawamura M; Abe M; Chou T; Asaoku H; Kitahara Y; Hayashi K; Kosaka M; Togawa A; Takatsuki K;
    Eur J Haematol; 2004 Sep; 73(3):169-73. PubMed ID: 15287913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous stem cell transplantation in multiple myeloma: a single center experience.
    Patriarca F; Fanin R; Silvestri F; Damiani D; Baccarani M
    Haematologica; 1998 May; 83(5):477-9. PubMed ID: 9658737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes following myeloablative allogeneic transplantation for multiple myeloma compared to autologous transplantation and the impact of graft-versus-myeloma effect.
    Khaled Y; Mellacheruvu S; Reddy P; Peres E; Mineishi S
    Bone Marrow Transplant; 2009 Sep; 44(5):325-6. PubMed ID: 19204708
    [No Abstract]   [Full Text] [Related]  

  • 10. IgD multiple myeloma--a clinical profile and outcome with chemotherapy and autologous stem cell transplantation.
    Wechalekar A; Amato D; Chen C; Keith Stewart A; Reece D
    Ann Hematol; 2005 Feb; 84(2):115-7. PubMed ID: 15503021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cell transplantation in multiple myeloma.
    Pant S; Copelan EA
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):877-85. PubMed ID: 17640590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma.
    Eom HS; Min CK; Cho BS; Lee S; Lee JW; Min WS; Kim CC; Kim M; Kim Y
    Jpn J Clin Oncol; 2009 Jul; 39(7):449-55. PubMed ID: 19487425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of autologous and allogeneic hematopoietic cell transplant therapy for multiple myeloma.
    Arora M; McGlave PB; Burns LJ; Miller JS; Barke JN; Defor TE; Weisdorf DJ
    Bone Marrow Transplant; 2005 Jun; 35(12):1133-40. PubMed ID: 15834435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of stem cell transplantation.
    Harousseau JL
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1157-74, x. PubMed ID: 17996593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
    Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V
    Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of statin use at the time of autologous transplant on response and survival in multiple myeloma.
    Hamadani M; Hade E; Benson DM; Hofmeister CC
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):351-2. PubMed ID: 18275902
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hematopoietic stem cell transplantation for multiple myeloma].
    Miwa A
    Rinsho Ketsueki; 1997 Apr; 38(4):296-301. PubMed ID: 9146055
    [No Abstract]   [Full Text] [Related]  

  • 18. Health-related quality of life in multiple myeloma survivors treated with high dose chemotherapy followed by autologous peripheral blood progenitor cell transplantation: a retrospective analysis.
    Slovacek L; Slovackova B; Pavlik V; Hrstka Z; Macingova Z; Jebavy L; Horacek JM
    Neoplasma; 2008; 55(4):350-5. PubMed ID: 18505348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
    Klaus J; Herrmann D; Breitkreutz I; Hegenbart U; Mazitschek U; Egerer G; Cremer FW; Lowenthal RM; Huesing J; Fruehauf S; Moehler T; Ho AD; Goldschmidt H
    Eur J Haematol; 2007 Jan; 78(1):21-8. PubMed ID: 17042762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuing erythropoietin during peripheral blood stem cell collection in myeloma: can it reduce toxicity of autologous transplants?
    Labonté L; Iqbal T; McDiarmid S; Bence-Bruckler I; Huebsch L; Allan D
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):132-3. PubMed ID: 18158970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.